Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine vs donepezil in moderate to severe Alzheimer's disease
CTR20140717Phase 2Suspended
- Sponsor
- Xinghu Pharmaceutical
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in Alzheimer's disease (AD), sponsored by Xinghu Pharmaceutical. Started Nov 2014; status: suspended.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20140717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140717.